32 results on '"Fusariosis therapy"'
Search Results
2. Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19.
- Author
-
Poignon C, Blaize M, Vezinet C, Lampros A, Monsel A, and Fekkar A
- Subjects
- Antifungal Agents therapeutic use, Betacoronavirus isolation & purification, COVID-19, Coronavirus Infections diagnosis, Coronavirus Infections therapy, Fusariosis diagnosis, Fusariosis therapy, Fusarium drug effects, Fusarium isolation & purification, Humans, Immunocompetence, Intubation, Intratracheal, Male, Middle Aged, Pandemics, Pneumonia, Viral diagnosis, Pneumonia, Viral therapy, SARS-CoV-2, Treatment Outcome, Coronavirus Infections complications, Critical Illness, Fusariosis complications, Pneumonia, Viral complications
- Published
- 2020
- Full Text
- View/download PDF
3. Simultaneous Triple Microbial Keratitis.
- Author
-
Jun JH
- Subjects
- Aged, Anti-Bacterial Agents therapeutic use, Antifungal Agents therapeutic use, Corneal Ulcer microbiology, Corneal Ulcer therapy, Drug Therapy, Combination, Eye Enucleation, Eye Infections, Bacterial microbiology, Eye Infections, Bacterial therapy, Eye Infections, Fungal microbiology, Eye Infections, Fungal therapy, Fusariosis microbiology, Fusariosis therapy, Fusarium isolation & purification, Humans, Male, Staphylococcal Infections microbiology, Staphylococcal Infections therapy, Staphylococcus isolation & purification, Streptococcal Infections microbiology, Streptococcal Infections therapy, Streptococcus salivarius isolation & purification, Coinfection, Corneal Ulcer diagnosis, Eye Infections, Bacterial diagnosis, Eye Infections, Fungal diagnosis, Fusariosis diagnosis, Staphylococcal Infections diagnosis, Streptococcal Infections diagnosis
- Abstract
Competing Interests: No potential conflict of interest relevant to this article was reported.
- Published
- 2019
- Full Text
- View/download PDF
4. Invasive fusariosis masquerading as extramedullary disease in rapidly progressive acute lymphoblastic leukemia.
- Author
-
Ligon JA, Natarajan M, Shalabi H, Yates B, Bishop R, Bianchi D, Alencar A, Lionakis MS, and Shah NN
- Subjects
- Adult, Fusariosis therapy, Humans, Male, Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy, Fusariosis microbiology, Fusariosis pathology, Precursor Cell Lymphoblastic Leukemia-Lymphoma microbiology, Precursor Cell Lymphoblastic Leukemia-Lymphoma pathology
- Abstract
Invasive fusariosis (IF) most commonly occurs in patients with hematologic malignancies and severe neutropenia, particularly during concomitant corticosteroid use. Breakthrough infections can occur in high-risk patients despite Aspergillus-active antifungal prophylaxis. We describe a patient with rapid acute lymphoblastic leukemia (ALL) progression who presented with multifocal skin nodules thought to be choloromatous disease. These lesions were ultimately diagnosed as IF and the patient had two simultaneously active disease processes. This case highlights the importance of pathologic diagnosis of new skin lesions in ALL patients, even during leukemia progression, and demonstrates that IF can occur despite normal neutrophil counts and Aspergillus-active prophylaxis., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
5. [Successful treatment of pre-engraftment disseminated fusariosis with high-dose liposomal amphotericin B in a cord blood transplant recipient].
- Author
-
Harada Y, Murata M, Matsumoto A, Kato D, Yagi T, Yaguchi T, Yoshikawa T, Takeichi T, Akiyama M, Yamaguchi Y, Koyama D, Terakura S, Nishida T, and Kiyoi H
- Subjects
- Antifungal Agents, Humans, Male, Middle Aged, Amphotericin B therapeutic use, Cord Blood Stem Cell Transplantation, Fusariosis therapy
- Abstract
A 47-year-old man with acute myeloid leukemia and myelodysplastic-related changes relapsed after an allogenic bone marrow transplant and received a cord blood transplant as salvage therapy. The patient developed febrile neutropenia that was resistant to broad-spectrum antibiotics and multiple, painful, nodular skin lesions on his trunk and extremities before engraftment. A skin biopsy and blood culture found mold, and the subsequent microscopic examination, mass spectrometry, and DNA sequencing of the fungal colonies identified Fusarium solani. The patient's fever and skin lesions began to improve with the administration of liposomal amphotericin B at 5 mg/kg/day. Neutrophilic engraftment occurred on day 19. Stage 3 acute skin graft-versus-host disease was cured by the application of topical steroid. Unexpectedly, a change from liposomal amphotericin B to voriconazole on day 38 exacerbated the Fusarium infection. The Fusarium infection was finally cured by the administration of liposomal amphotericin B for a total of 19 weeks. Neutrophilic engraftment, an immediate definitive diagnosis, the sufficient and long-term administration of appropriate antifungal medication, and avoidance of the systemic administration of steroids might have contributed to the successful outcome of this patient.
- Published
- 2019
- Full Text
- View/download PDF
6. Case Report: Corneal Coinfection with Fungus and Amoeba : Report of Two Patients and Literature Review.
- Author
-
Joseph J, Chaurasia S, and Sharma S
- Subjects
- Acanthamoeba Keratitis therapy, Adult, Aged, Female, Fusariosis therapy, Humans, Keratoplasty, Penetrating, Male, Acanthamoeba Keratitis complications, Coinfection microbiology, Coinfection parasitology, Fusariosis complications, Fusarium isolation & purification
- Abstract
We report two cases of corneal coinfection with Acanthamoeba and Fusarium sp. along with the review of published literature. A 35-year-old woman and 65-year-old man presented to the institute with corneal ulcer refractory for treatment with topical antibiotics. Microbiological examination revealed the presence of Acanthamoeba cysts along with septate, hyaline fungal filaments. After emergency therapeutic penetrating keratoplasty (TPK) in both, the corneal tissue was sent for histopathologic examination, which confirmed the presence of Acanthamoeba and fungal coinfection. One patient had a recurrence of fungal infection after TPK. In subjects with a rapid progression of mycotic ulcer, coinfection with other microorganisms including Acanthamoeba should be suspected. The two cases presented here emphasize the importance of microbiology in making prompt diagnosis and appropriate management of these cases at an early stage.
- Published
- 2018
- Full Text
- View/download PDF
7. Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications.
- Author
-
Yoshida M, Kiyota N, Maruyama K, Kunikata H, Toyokawa M, Hagiwara S, Makimura K, Sato N, Taniuchi S, and Nakazawa T
- Subjects
- Adolescent, Amphotericin B administration & dosage, Dermatomycoses diagnosis, Dermatomycoses pathology, Endophthalmitis pathology, Fusariosis pathology, Fusarium isolation & purification, Humans, Leukemia, Myeloid, Acute drug therapy, Lung Diseases, Fungal diagnosis, Lung Diseases, Fungal pathology, Male, Splenic Diseases diagnosis, Splenic Diseases pathology, Treatment Outcome, Voriconazole administration & dosage, Antifungal Agents administration & dosage, Endophthalmitis diagnosis, Endophthalmitis therapy, Fusariosis diagnosis, Fusariosis therapy, Leukemia, Myeloid, Acute complications, Vitrectomy
- Abstract
Endogenous fungal endophthalmitis (EFE) caused by disseminated fusariosis is a rare condition that generally has a poor outcome, even with intensive therapy. Here, we describe a case in which this type of EFE was diagnosed with vitreous sampling and was successfully treated with 25-gauge vitrectomy and antifungals, including liposomal amphotericin B and voriconazole. A 16-year-old male patient undergoing treatment for acute myeloid leukemia complained of eye pain and blurred vision in his right eye. Treatment was initiated for a vitreous opacity, possibly associated with herpetic retinitis, but the patient worsened and he was referred to us. Right-eye visual acuity was limited to light perception. We suspected endogenous endophthalmitis and performed 25-gauge vitrectomy with antibiotic perfusion of ceftazidime, vancomycin, and voriconazole. Vitreous culturing revealed the presence of Fusarium solani species complex, and enhanced computed tomography revealed disseminated fusariosis lesions in the lung, spleen, and the soft tissue of the left upper arm. The patient received antifungal treatment with liposomal amphotericin B and voriconazole, and these conditions were eliminated. Visual acuity recovered to 20/400 after additional vitrectomy for tractional retinal detachment and was maintained at this level during the 6-month follow-up period. The success of our treatment allowed the capture of optical coherence tomography images of the retina during fusarium-associated endogenous endophthalmitis and the follow-up period. Furthermore, this case showed that immediate vitrectomy for suspected EFE and intensive treatment can lead to a good clinical outcome.
- Published
- 2018
- Full Text
- View/download PDF
8. Eosinophil fungal rhinosinusitis caused by Fusarium infection secondary to odontogenic maxillary sinus disease: when collaboration between otolaryngologist and allergologist leads to the correct diagnosis and therapy.
- Author
-
Gamba P and Lombardi C
- Subjects
- Allergy and Immunology, Eosinophils physiology, Fusariosis therapy, GPI-Linked Proteins, Humans, Intersectoral Collaboration, Male, Middle Aged, Rhinitis therapy, Serine Endopeptidases, Sinusitis therapy, Dental Implants adverse effects, Fusariosis diagnosis, Maxillary Sinus, Otolaryngologists, Rhinitis diagnosis, Sinusitis diagnosis
- Abstract
Summary: Rhinitis and sinusitis usually coexist and are concurrent in most individuals; thus, the correct terminology is now "rhinosinusitis". On the basis of numerous causative factors, often co-existing in the same patient, the diagnosis of rhinosinusitis is also made by a wide variety of practitioners (allergologists, otolaryngologists, pulmonologists, primary care physicians, paediatricians, and many others). Approximately 5-15% of the population suffers from chronic rhinosinusitis, and in 10-12% of them, it is of dental origin. The treatment of odontogenic maxillary sinus disease is directed to the management of the rhinosinusitis and of the odontogenic source. The widespread use of dental implants and reconstructive procedures for dental implant placement has led to new types of complication, as in this case report, due to chronic eosinophilic rhinosinusitis secondary to Fusarium infection in the maxillary sinus. The patient was initially evaluated by the allergologist, and subsequently successfully treated by the otolaryngologist with Functional Endoscopic Sinus Surgery. The advantages of endoscopic sinus surgery include more accurate visualization, no external incision, reduced soft tissue dissection, and reduced hospital stay. Chronic maxillary sinusitis of dental origin is a common disease that requires treatment of the sinusitis as well as of the odontogenic source.
- Published
- 2017
9. [Fusarium keratitis with dramatic outcome].
- Author
-
Lübke J, Auw-Hädrich C, Meyer-Ter-Vehn T, Emrani E, and Reinhard T
- Subjects
- Eye Enucleation, Female, Humans, Middle Aged, Treatment Failure, Antifungal Agents therapeutic use, Eye Infections, Fungal diagnosis, Eye Infections, Fungal therapy, Fusariosis diagnosis, Fusariosis therapy, Keratitis diagnosis, Keratitis therapy
- Abstract
Background: Fungal keratitis is much less common in Europe than in Asia. Antifungal therapy can be applied topically as well as systemically and in advanced situations surgical intervention can become necessary., Case Report: We present the case of a 60-year-old woman who suffered from Fusarium keratitis that showed progression to endophthalmitis following contact lens wearing. Due to numerous resistances against antimycotic drugs the eye had to be enucleated to prevent the pathogens from spreading. Histologically, major inflammatory activity could be detected but no causative organism could be found. The failure to detect a pathogen was in clear contrast to the clinical findings and was interpreted as being an overreaction of the immune response even after the Fusarium had been destroyed., Conclusion: If a fungal infection of the cornea is suspected, antimycotic therapy should be initiated as early as possible. In cases involving highly resistant pathogens the eye cannot always be saved.
- Published
- 2017
- Full Text
- View/download PDF
10. Invasive fungal sinusitis in the pediatric population: Systematic review with quantitative synthesis of the literature.
- Author
-
Smith A, Thimmappa V, Shepherd B, Ray M, Sheyn A, and Thompson J
- Subjects
- Amphotericin B therapeutic use, Anemia, Aplastic immunology, Aspergillosis immunology, Aspergillosis microbiology, Aspergillosis mortality, Aspergillosis therapy, Burkitt Lymphoma immunology, Candidiasis, Invasive immunology, Candidiasis, Invasive microbiology, Candidiasis, Invasive mortality, Candidiasis, Invasive therapy, Child, Facial Pain etiology, Female, Fusariosis immunology, Fusariosis microbiology, Fusariosis mortality, Fusariosis therapy, Humans, Immunocompromised Host, Leukemia immunology, Male, Mucormycosis immunology, Mucormycosis microbiology, Mucormycosis mortality, Mucormycosis therapy, Mycoses immunology, Mycoses microbiology, Mycoses mortality, Neutropenia immunology, Prognosis, Retrospective Studies, Sinusitis immunology, Sinusitis microbiology, Sinusitis mortality, Antifungal Agents therapeutic use, Mycoses therapy, Otorhinolaryngologic Surgical Procedures, Sinusitis therapy
- Abstract
Background: Invasive fungal sinusitis (IFS) represents an often fatal condition within the pediatric population. In an effort to characterize demographics, treatment modalities, and prognostic factors, we performed a systematic review., Methods: We systematically reviewed EMBASE, Medline, TRIPdatabase, SCOPUS and the Cochrane database for invasive fungal nasal and sinus infections limited to individuals <18 years of age. Case series including 3 or more patients were included. Demographics, treatment and outcomes were analyzed using R Gui statistical software., Results: Twelve studies met inclusion criteria (103 patients). There was male preponderance of 48.5% with median age of 11 years old. Majority of patients had underlying leukemia (44.6%). Aspergillus was the predominant organism (47%). Isolated nasal findings occurred in 14% of patients and nasal findings occurred in 49% overall. Absolute neutrophil count (ANC) of immunocompromised patients was below 600 in most patients (99%). Average and median length of neutropenia was 2 weeks. All patients were prescribed amphoterocin with 50% as single medicinal therapy. Surgery occurred in 82.8% of cases. The mortality rate was 46%. Univariate analysis identified presenting with facial pain as a negative predictor of overall mortality (OR 0.296, 95% CI: 0.104-0.843, p < 0.05)., Conclusion: Mortality remains high in pediatric patients with IFS. An ANC of <600 occurred in the majority of immunocompromised patients at a duration of 2 weeks. Presenting with facial pain was a negative predictor of mortality. Many studies label this condition as invasive fungal sinusitis; however, approximately one seventh presented with only nasal findings and half overall had nasal involvement., (Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
11. Anterior Segment Optical Coherence Tomography of Patients With Late-Onset Tunnel Fungal Infections With Endophthalmitis After Cataract Surgery.
- Author
-
Kitahata M, Suzuki T, Oka N, Toriyama K, and Ohashi Y
- Subjects
- Aged, Antifungal Agents therapeutic use, Combined Modality Therapy, Endophthalmitis microbiology, Endophthalmitis therapy, Eye Infections, Fungal microbiology, Eye Infections, Fungal therapy, Female, Fusariosis microbiology, Fusariosis therapy, Fusarium isolation & purification, Humans, Male, Ophthalmologic Surgical Procedures, Sclera, Surgical Wound Infection microbiology, Surgical Wound Infection therapy, Tomography, Optical Coherence, Anterior Eye Segment diagnostic imaging, Cataract Extraction, Endophthalmitis diagnostic imaging, Eye Infections, Fungal diagnostic imaging, Fusariosis diagnostic imaging, Surgical Flaps microbiology, Surgical Wound Infection diagnostic imaging
- Abstract
Purpose: To report the use of anterior segment optical coherence tomography for characterization of late-onset tunnel fungal infections with endophthalmitis after cataract surgery., Methods: Case reports., Results: A 77-year-old female (case 1) and a 76-year-old male (case 2) who received cataract surgery 15 and 1 year before their initial visits, respectively, were treated with topical steroids based on a diagnosis of uveitis, because they showed growing white lesions on the upper iris and beneath the cataract scleral wound. Irrigation of the anterior chambers and removal of the white lesions were performed in each case, and microbiological tests were positive for fungi (case 1, a positive culture of Fusarium sp.; case 2, a filamentous fungus present in a direct smear) in the white lesions. Both cases were diagnosed as late-onset fungal endophthalmitis after cataract surgery and were treated with topical and systemic antifungal agents. However, the white lesions reappeared, and the inflammation in the anterior chambers worsened. Anterior segment optical coherence tomography showed the spread of the white lesions into the scleral incisions from cataract surgery. Deroofing of the tunnel and sclerocorneal patch grafts were performed in both cases to treat the fungal tunnel infections. After these treatments, inflammation of both corneas and anterior chambers subsided., Conclusions: Anterior segment optical coherence tomography can be used to identify late-onset fungal tunnel infections with endophthalmitis after cataract surgery.
- Published
- 2016
- Full Text
- View/download PDF
12. Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.
- Author
-
Riches ML, Trifilio S, Chen M, Ahn KW, Langston A, Lazarus HM, Marks DI, Martino R, Maziarz RT, Papanicolou GA, Wingard JR, Young JA, and Bennett CL
- Subjects
- Acute Disease, Adolescent, Adult, Age Factors, Aged, Allografts, Aspergillus, Child, Child, Preschool, Disease-Free Survival, Female, Graft vs Host Disease etiology, Graft vs Host Disease mortality, Graft vs Host Disease therapy, Humans, Male, Middle Aged, Risk Factors, Survival Rate, Fusariosis etiology, Fusariosis mortality, Fusariosis therapy, Hematopoietic Stem Cell Transplantation, Mucormycosis etiology, Mucormycosis mortality, Mucormycosis therapy
- Abstract
Risk factors for non-Aspergillus mold infection (NAMI) and the impact on transplant outcome are poorly assessed in the current era of antifungal agents. Outcomes of 124 patients receiving allogeneic hematopoietic cell transplantation (HCT) diagnosed with either mucormycosis (n=72) or fusariosis (n=52) between days 0 and 365 after HCT are described and compared with a control cohort (n=11 856). Patients with NAMI had more advanced disease (mucormycois: 25%, fusariosis: 23% and controls: 18%; P=0.004) and were more likely to have a Karnofsky performance status (KPS) <90% at HCT (mucormycosis: 42%, fusariosis: 38% and controls: 28%; P=0.048). The 1-year survival after HCT was 22% (15-29%) for cases and was significantly inferior compared with controls (65% (64-65%); P<0.001). Survival from infection was similarly dismal regardless of mucormycosis: 15% (8-25%) and fusariosis: 21% (11-33%). In multivariable analysis, NAMI was associated with a sixfold higher risk of death (P<0.0001) regardless of the site or timing of infection. Risk factors for mucormycosis include preceding acute GvHD, prior Aspergillus infection and older age. For fusariosis, increased risks including receipt of cord blood, prior CMV infection and transplant before May 2002. In conclusion, NAMI occurs infrequently, is associated with high mortality and appears with similar frequency in the current antifungal era.
- Published
- 2016
- Full Text
- View/download PDF
13. CD34+ highly enriched allogeneic stem cell transplantation in a patient with mixed phenotype acute leukemia and Fusarium solani sepsis.
- Author
-
Kordelas L, Gromke T, Trenschel R, Ditschkowski M, Koldehoff M, and Beelen DW
- Subjects
- Fusariosis complications, Fusarium, Humans, Leukemia, Biphenotypic, Acute complications, Sepsis complications, Transplantation, Homologous methods, Antigens, CD34 administration & dosage, Fusariosis therapy, Leukemia, Biphenotypic, Acute therapy, Sepsis therapy, Stem Cell Transplantation methods
- Published
- 2016
- Full Text
- View/download PDF
14. Bone and joint infections by Mucorales, Scedosporium, Fusarium and even rarer fungi.
- Author
-
Koehler P, Tacke D, and Cornely OA
- Subjects
- Arthritis diagnosis, Arthritis epidemiology, Arthritis therapy, Diagnostic Imaging, Disease Management, Fusariosis diagnosis, Fusariosis epidemiology, Fusariosis microbiology, Fusariosis therapy, Humans, Immunocompromised Host, Incidence, Molecular Diagnostic Techniques, Mucormycosis diagnosis, Mucormycosis epidemiology, Mucormycosis microbiology, Mucormycosis therapy, Osteitis diagnosis, Osteitis epidemiology, Osteitis therapy, Arthritis microbiology, Fusarium physiology, Mucorales physiology, Osteitis microbiology, Scedosporium physiology
- Abstract
Mucorales, Scedosporium and Fusarium species are rarely considered as cause for bone and joint infections. However, these moulds are emerging as important fungal pathogens in immunocompromised and immunocompetent patients. Typical pre-disposing host conditions are immunosuppression and diabetes. Most common causative pathogens are Mucorales followed by Scedosporium and Fusarium. Acremonium and Phialemonium species are rare but some case reports exist. MRI is the gold standard imaging technique. Tissue specimens obtained as aspirates, imaging guided biopsy or open surgery need mycological and histopathological work-up for genus and species identification. Multimodal treatment strategies combine surgical debridement, drainage of joints or abscesses, removal of infected prosthetic joints and systemic antifungals. The treatment of mucormycosis is polyene based and may be combined with either posaconazole or - in rare cases - caspofungin. As Scedosporium species are intrinsically resistant to polyenes and azoles show absence of in vitro activity, voriconazole plus synergistic treatment regimens become the therapeutic standard. In fusariosis, fungal susceptibility is virtually impossible to predict, so that combination treatment of voriconazole and lipid-based amphotericin B should be the first-line strategy while susceptibility results are pending. In the absence of randomized controlled trials, infections due to the above moulds should be registered, e.g. in the registries of the European Confederation of Medical Mycology (ECMM).
- Published
- 2016
- Full Text
- View/download PDF
15. Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience.
- Author
-
Kadri SS, Remy KE, Strich JR, Gea-Banacloche J, and Leitman SF
- Subjects
- Female, Fusariosis epidemiology, Humans, Male, Fusariosis therapy, Granulocytes transplantation, Leukocyte Transfusion methods
- Abstract
Background: Invasive Fusarium infection is relatively refractory to available antifungal agents. Invasive fusariosis (IF) occurs almost exclusively in the setting of profound neutropenia and/or systemic corticosteroid use. Treatment guidelines for IF are not well established, including the role of granulocyte transfusions (GTs) to counter neutropenia., Study Design and Methods: We conducted a systematic review, identifying IF cases where GTs were used as adjunctive therapy to antifungal agents and also report a single-center case series detailing our experience (1996-2012) of all IF cases treated with antifungal agents and GTs. In the systematic review cases, GTs were predominantly collected from nonstimulated donors whereas, in the case series, they were universally derived from dexamethasone- and granulocyte-colony-stimulating factor-stimulated donors., Results: Twenty-three patients met inclusion criteria for the systematic review and 11 for the case series. Response rates after GTs were 30 and 91% in the review and case series, respectively. Survival to hospital discharge remained low at 30 and 45%, respectively. Ten patients in the systematic review and three in the case series failed to achieve hematopoietic recovery and none of these survived. In the case series, donor-stimulated GTs generated mean "same-day" neutrophil increments of 3.35 × 10(9) ± 1.24 × 10(9) /L and mean overall posttransfusion neutrophil increments of 2.46 × 10(9) ± 0.85 × 10(9) /L. Progressive decrements in neutrophil response to GTs in two cases were attributed to GT-related HLA alloimmunization., Conclusion: In patients with IF, donor-stimulated GTs may contribute to high response rates by effectively bridging periods of neutropenia or marrow suppression. However, their utility in the absence of neutrophil recovery remains questionable., (Published 2015. This article is a U.S. Government work and is in the public domain in the USA.)
- Published
- 2015
- Full Text
- View/download PDF
16. Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report.
- Author
-
Akers KS, Rowan MP, Niece KL, Graybill JC, Mende K, Chung KK, and Murray CK
- Subjects
- Adult, Amphotericin B therapeutic use, Amputation, Surgical, Antifungal Agents therapeutic use, Aspergillosis therapy, Blast Injuries microbiology, Blast Injuries therapy, Burns microbiology, Critical Illness, Debridement, Drug Monitoring, Fusariosis therapy, Humans, Male, Mucormycosis therapy, Voriconazole therapeutic use, War-Related Injuries microbiology, Wounds, Penetrating microbiology, Amphotericin B pharmacokinetics, Antifungal Agents pharmacokinetics, Burns therapy, Mycoses therapy, Voriconazole pharmacokinetics, War-Related Injuries therapy, Wounds, Penetrating therapy
- Abstract
Background: Survivors of combat trauma can have long and challenging recoveries, which may be complicated by infection. Invasive fungal infections are a rare but serious complication with limited treatment options. Currently, aggressive surgical debridement is the standard of care, with antifungal agents used adjunctively with uncertain efficacy. Anecdotal evidence suggests that antifungal agents may be ineffective in the absence of surgical debridement, and studies have yet to correlate antifungal concentrations in plasma and wounds., Case Presentation: Here we report the systemic pharmacokinetics and wound effluent antifungal concentrations of five wounds from two male patients, aged 28 and 30 years old who sustained combat-related blast injuries in southern Afghanistan, with proven or possible invasive fungal infection. Our data demonstrate that while voriconazole sufficiently penetrated the wound resulting in detectable effluent levels, free amphotericin B (unbound to plasma) was not present in wound effluent despite sufficient concentrations in circulating plasma. In addition, considerable between-patient and within-patient variability was observed in antifungal pharmacokinetic parameters., Conclusion: These data highlight the need for further studies evaluating wound penetration of commonly used antifungals and the role for therapeutic drug monitoring in providing optimal care for critically ill and injured war fighters.
- Published
- 2015
- Full Text
- View/download PDF
17. Black plaques and white nodules in a burn patient. Fusarium and Mucormycosis.
- Author
-
Atty C, Alagiozian-Angelova VM, and Kowal-Vern A
- Subjects
- Adult, Burns therapy, Fatal Outcome, Fusariosis therapy, Humans, Male, Mucormycosis therapy, Burns complications, Fusariosis complications, Mucormycosis complications
- Published
- 2014
- Full Text
- View/download PDF
18. [Invasive fungal disease due to Scedosporium, Fusarium and mucorales].
- Author
-
Pemán J and Salavert M
- Subjects
- Antifungal Agents therapeutic use, Combined Modality Therapy, Communicable Diseases, Emerging diagnosis, Communicable Diseases, Emerging therapy, Debridement, Early Diagnosis, Fungemia diagnosis, Fungemia therapy, Humans, Immunocompromised Host, Immunosuppressive Agents adverse effects, Mycology methods, Neoplasms complications, Neoplasms immunology, Neutropenia complications, Opportunistic Infections diagnosis, Opportunistic Infections microbiology, Opportunistic Infections therapy, Organ Transplantation, Postoperative Complications microbiology, Communicable Diseases, Emerging microbiology, Fungemia microbiology, Fusariosis diagnosis, Fusariosis therapy, Mucormycosis diagnosis, Mucormycosis therapy, Pseudallescheria isolation & purification, Scedosporium isolation & purification
- Abstract
The number of emerging organisms causing invasive fungal infections has increased in the last decades. These etiological agents include Scedosporium, Fusarium and mucorales. All of them can cause disseminated, virulent, and difficult-to treat infections in immunosuppressed patients, the most affected, due to their resistance to most available antifungal agents. Current trends in transplantation including the use of new immunosuppressive treatments, the common prescription of antifungal agents for prophylaxis, and new ecological niches could explain the emergence of these fungal pathogens. These pathogens can also affect immunocompetent individuals, especially after natural disasters (earthquakes, floods, tsunamis), combat wounds or near drowning. All the invasive infections caused by Scedosporium, Fusarium, and mucorales are potentially lethal and a favourable outcome is associated with rapid diagnosis by direct microscopic examination of the involved tissue, wide debridement of infected material, early use of antifungal agents including combination therapy, and an improvement in host defenses, especially neutropenia., (Copyright © 2014. Published by Elsevier Espana.)
- Published
- 2014
- Full Text
- View/download PDF
19. An unusual cause of an ankle mass.
- Author
-
Prinja A, Roberts C, Doherty T, and Oddy MJ
- Subjects
- Adult, Humans, Male, Ankle surgery, Antifungal Agents therapeutic use, Cytoreduction Surgical Procedures, Fusariosis therapy, Mycetoma therapy, Soft Tissue Infections therapy
- Abstract
We report the case of a patient who presented with a 7-year history of a mass over the medial aspect of his right ankle, which had been gradually increasing in size. He had given up his occupation as a bus driver due to decreased movement of his ankle. An initial diagnosis of endemic syphilis was made after treponemal antibody and treponema pallidum particle agglutination tests were positive. However, following surgical debulking, cultures grew Fusarium solani and the diagnosis was changed to eumycetoma. He received prolonged treatment with antifungal agents and at 18 months follow-up remains well., (2014 BMJ Publishing Group Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
20. Subcutaneous hyalohyphomycosis caused by Fusarium in a kidney transplant recipient.
- Author
-
Keskar VS, Wanjare S, Jamale TE, Mahajan D, Jawale SY, Fernandes G, Suryawanshi R, and Hase NK
- Subjects
- Adult, Female, Fusariosis therapy, Humans, Hyalohyphomycosis diagnosis, Hyalohyphomycosis therapy, Kidney Transplantation, Postoperative Complications diagnosis, Postoperative Complications therapy, Fusariosis diagnosis, Fusarium isolation & purification, Hyalohyphomycosis microbiology, Postoperative Complications microbiology
- Abstract
Fusarium is a filamentous opportunistic pathogenic fungus responsible for superficial as well as invasive infection in immunocompromized hosts. Net state of immunosuppression and cytomegalovirus (CMV) infection appear to predispose to this disease which is life-threatening when disseminated. Though infections with Fusarium have been widely described in hematological malignancies and hematopoietic stem cell transplant cases, they have been reported to be rare in solid organ transplant recipients, are often localized and carry a favorable prognosis. We here describe a rare case of subcutaneous non-invasive infection with Fusarium in a renal allograft recipient two and half years after transplantation. Patient had a previous history of CMV infection along with multiple other recurrent co-infections. Diagnosis was based on culture of tissue specimens yielding Fusarium species. The infection had a protracted course with persistence of lesions after treatment with voriconazole alone, requiring a combination of complete surgical excision and therapy with the anti-fungal drug.
- Published
- 2014
- Full Text
- View/download PDF
21. Fusarium peritonitis successfully managed with posaconazole and catheter removal.
- Author
-
Shah PJ, Bergman S, Vegi S, and Sundareshan V
- Subjects
- Adult, Antifungal Agents therapeutic use, Catheter-Related Infections microbiology, Catheter-Related Infections therapy, Catheters, Indwelling microbiology, Equipment Contamination, Female, Follow-Up Studies, Fusariosis microbiology, Fusariosis therapy, Humans, Kidney Failure, Chronic therapy, Peritonitis microbiology, Peritonitis therapy, Catheter-Related Infections etiology, Catheters, Indwelling adverse effects, Device Removal methods, Fusariosis etiology, Fusarium isolation & purification, Peritonitis etiology, Triazoles therapeutic use
- Published
- 2014
- Full Text
- View/download PDF
22. Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis.
- Author
-
Choi KS, Yoon SC, Rim TH, Han SJ, Kim ED, and Seo KY
- Subjects
- Animals, Antifungal Agents administration & dosage, Combined Modality Therapy methods, Eye Infections, Fungal pathology, Fusariosis pathology, Fusarium drug effects, Fusarium radiation effects, Humans, Keratitis pathology, Rabbits, Treatment Outcome, Eye Infections, Fungal therapy, Fusariosis therapy, Fusarium isolation & purification, Keratitis therapy, Ultraviolet Therapy methods, Voriconazole administration & dosage
- Abstract
Purpose: To demonstrate that ultraviolet-A (UV-A) and voriconazole combination therapy is more effective than voriconazole single treatment for fungal keratitis., Methods: The in vitro UV-A (375 nm) fungicidal effect was evaluated on Fusarium solani solutions. Each fungal solution was irradiated with different UV-A irradiation doses. Also, a fungal solution containing voriconazole was also irradiated with UV-A. The in vivo therapeutic effect of UV-A and voriconazole treatment was studied in a rabbit keratitis model. Fungi were injected intrastromally into the cornea of 16 rabbits. Each treatment was initiated 3 days after fungal injection and continued up to 8 days for the following groups: Group 1, control; Group 2, treated with UV-A once a day; Group 3, treated with voriconazole 3 times a day; Group 4, treated with voriconazole 3 times a day and UV-A once a day. On the last day, the sclera-cornea buttons were extracted and microbiological and histological evaluations were performed., Results: The colony-forming units (CFUs) of fungal solutions in culture significantly decreased with UV-A irradiation. The CFUs of fungal solutions containing voriconazole also decreased with UV-A irradiation. In vivo, clinical scores of Group 3 (P=0.03) and Group 4 (P=0.02) 5 days after treatment were significantly lower compared to that of Group 1. The clinical score of Group 4 (P=0.03) 5 days after treatment was significantly lower compared to that of Group 3. The histopathological scores 5 days after treatment were significantly lower in Group 4 compared to those of Group 1 (P<0.01) and Group 3 (P=0.02). Based on our CFU analysis, only Group 4 showed significantly lower CFUs compared to Group 1 (P=0.04)., Conclusions: UV-A and voriconazole combination treatment could be a safe and effective alternative to voriconazole single treatment for fungal keratitis.
- Published
- 2014
- Full Text
- View/download PDF
23. [Successful treatment of Fusarium-associated keratitis with multiresistant pathogen and multimorbid patient].
- Author
-
Alnawaiseh M, Böhm MR, Idelevich EA, Becker K, Grewe S, Grenzebach UH, and Eter N
- Subjects
- Aged, Combined Modality Therapy, Drug Resistance, Multiple, Fungal, Fusariosis diagnosis, Fusarium, Humans, Keratitis diagnosis, Male, Treatment Outcome, Antifungal Agents therapeutic use, Corneal Transplantation methods, Fusariosis microbiology, Fusariosis therapy, Keratitis microbiology, Keratitis therapy, Scleroplasty methods
- Abstract
A 75-year-old man (not a contact lens wearer) presented with Fusarium-associated hypopyon keratitis. After several weeks of empirical and subsequently targeted antimycotic treatment, no considerable improvement was observed. However, after sclerokeratoplasty (11.2 × 11.2 mm) combined with prolonged antimycotic therapy a good local result with relapse-free long-term follow-up was achieved.
- Published
- 2014
- Full Text
- View/download PDF
24. Clinicopathologic case reports of Alternaria and Fusarium keratitis in Canada.
- Author
-
Jiang K, Brownstein S, Baig K, Lam K, and Toye B
- Subjects
- Adult, Alternariosis diagnosis, Alternariosis therapy, Antifungal Agents administration & dosage, Canada, Corneal Ulcer diagnosis, Corneal Ulcer therapy, Eye Infections, Fungal diagnosis, Eye Infections, Fungal therapy, Fusariosis diagnosis, Fusariosis therapy, Humans, Keratoplasty, Penetrating, Male, Middle Aged, Alternaria isolation & purification, Alternariosis microbiology, Corneal Ulcer microbiology, Eye Infections, Fungal microbiology, Fusariosis microbiology, Fusarium isolation & purification
- Published
- 2013
- Full Text
- View/download PDF
25. Fusarium infection: report of 26 cases and review of 97 cases from the literature.
- Author
-
Muhammed M, Anagnostou T, Desalermos A, Kourkoumpetis TK, Carneiro HA, Glavis-Bloom J, Coleman JJ, and Mylonakis E
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Dermatomycoses therapy, Female, Fusariosis etiology, Fusariosis therapy, Fusarium isolation & purification, Humans, Male, Middle Aged, Opportunistic Infections therapy, Retrospective Studies, Young Adult, Dermatomycoses epidemiology, Fusariosis epidemiology, Opportunistic Infections epidemiology
- Abstract
Fusarium species is a ubiquitous fungus that causes opportunistic infections. We present 26 cases of invasive fusariosis categorized according to the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria of fungal infections. All cases (20 proven and 6 probable) were treated from January 2000 until January 2010. We also review 97 cases reported since 2000. The most important risk factors for invasive fusariosis in our patients were compromised immune system, specifically lung transplantation (n = 6) and hematologic malignancies (n = 5), and burns (n = 7 patients with skin fusariosis), while the most commonly infected site was the skin in 11 of 26 patients. The mortality rates among our patients with disseminated, skin, and pulmonary fusariosis were 50%, 40%, and 37.5%, respectively. Fusarium solani was the most frequent species, isolated from 49% of literature cases. Blood cultures were positive in 82% of both current study and literature patients with disseminated fusariosis, while the remaining 16% had 2 noncontiguous sites of infection but negative blood cultures. Surgical removal of focal lesions was effective in both current study and literature cases. Skin lesions in immunocompromised patients should raise the suspicion for skin or disseminated fusariosis. The combination of medical monotherapy with voriconazole or amphotericin B and surgery in such cases is highly suggested.
- Published
- 2013
- Full Text
- View/download PDF
26. Endobronchial cryotherapy for a mycetoma.
- Author
-
Rojas-Tula DG, Gómez-Fernández M, García-López JJ, Cobos-Ceballos MJ, Gil-Fuentes A, Pérez-Laya JM, Serrano-Rebollo JC, Ortega-González A, Vargas-Hidalgo T, Ruíz de Oña-Lacasta JM, and Celdrán-Gil J
- Subjects
- Amphotericin B administration & dosage, Amphotericin B therapeutic use, Antifungal Agents administration & dosage, Antifungal Agents therapeutic use, Cough diagnostic imaging, Cough therapy, Fusariosis diagnostic imaging, Fusariosis physiopathology, Hemoptysis diagnostic imaging, Hemoptysis etiology, Hemoptysis therapy, Humans, Instillation, Drug, Lung Diseases, Fungal diagnostic imaging, Lung Diseases, Fungal physiopathology, Male, Middle Aged, Mycetoma diagnostic imaging, Mycetoma physiopathology, Radiography, Recurrence, Tuberculosis, Pulmonary complications, Bronchoscopy methods, Cryotherapy methods, Fusariosis therapy, Lung Diseases, Fungal therapy, Mycetoma therapy
- Abstract
Mycetoma is defined as a fungus ball that fills a preexisting lung cavity, most frequently being of tuberculous or sarcoid etiology. The most frequently isolated fungus is the species of Aspergillus, but other fungi such as Fusarium or Zygomycetes can also be present. Most patients lack symptoms. However, presentation may also be with hemoptysis, which can be massive and life-threatening. We describe the case of a 50-year-old man with a history of prior pulmonary tuberculosis, with recurrent episodes of cough and hemoptysis. He was diagnosed to have mycetoma in the left upper lobe cavity. The mycetoma was extracted through bronchoscopy under general anesthesia using a cryoprobe. Treatment was completed with amphotericin B instilled in the cavity and the patient was placed on oral itraconazole. This is the first case report to date in which cryotherapy was used to remove a mycetoma.
- Published
- 2013
- Full Text
- View/download PDF
27. [Fusariosis diagnosed in the laboratory of an UH in Tunisia: epidemiological, clinical and mycological study].
- Author
-
Néji S, Trabelsi H, Cheikhrouhou F, Sellami H, Guidara R, Trigui A, Feki J, Boudaya S, Turki H, Makni F, and Ayadi A
- Subjects
- Adult, Aged, Aged, 80 and over, Antifungal Agents therapeutic use, Clinical Laboratory Techniques statistics & numerical data, Corneal Ulcer drug therapy, Corneal Ulcer epidemiology, Corneal Ulcer microbiology, Eye Infections, Fungal drug therapy, Eye Infections, Fungal epidemiology, Eye Infections, Fungal microbiology, Fusariosis diagnosis, Fusariosis therapy, Hospitals, University statistics & numerical data, Humans, Middle Aged, Onychomycosis drug therapy, Onychomycosis epidemiology, Onychomycosis microbiology, Retrospective Studies, Tunisia epidemiology, Young Adult, Fusariosis epidemiology, Fusariosis microbiology
- Abstract
The genus Fusarium, initially known for its important agro-economic impact, is more and more often implicated in human pathology. In fact, multiples allergic, toxic and infectious manifestations are more reported in immunocompetent and immunocompromised hosts. The objective of our study was to analyse the epidemiological, mycological and clinical features of fusariosis reported in our CHU. Eighty-seven cases of Fusarium infections were collected: 34 cases of onychomycosis (39%), 26 cases of intertrigos (30%), 25 cases of keratomycosis (29%), one case of atypical invasive fusariosis due to Fusarium oxysporum species complex (FOSC) and one case of localized gingivolabial fusariosis due to Fusarium solani species complex (FSSC) in a patient with leukemia in phase of deep bone marrow aplasia, whose outcome was favorable after exiting of aplasia period and a treatment by amphotericine B. The case of pseudotumoral cutaneous fusariosis to F. oxysporum complicated with osteolysis and septic arthritis occurred in a pregnant woman without any immune deficit. The evolution was fatal in spite of prescription of multiple systemic antifungals. Concerning keratomycosis, Fusarium was the first agent responsible for these infections (43%). The corneal traumatism was found in 37.5% of cases and FSSC was the most isolated (72%). For superficial dermatomycosis, Fusarium was the third agent of onychomycosis in molds (25%). The most isolated species were FSSC (68%) and FOSC (20%). The intertrigo frequency was 0.07% and they were mostly caused by FSSC (84%) and FOSC (16%). Fusarium is an important cause of mold infections in our region. So, the species identification is useful because some species are resistant to the most common systemic antifungal agents., (Copyright © 2013 Elsevier Masson SAS. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
28. [Skin infections caused by Fusarium].
- Author
-
Brasch J
- Subjects
- Fusariosis microbiology, Humans, Antifungal Agents administration & dosage, Fusariosis diagnosis, Fusariosis therapy, Fusarium
- Abstract
Under favorable conditions even molds can cause skin infections. Fusarium spp. belong to this group of agents. Onychomycoses due to Fusarium spp. are regularly encountered and cannot be clinically distinguished from nail infections triggered by dermatophytes. They can occur in otherwise healthy persons. Skin lesions caused by Fusarium spp. may be necrotizing, ulcerating, pustular, vasculitis-like, panniculitis-like or granulomatous. Single lesions can develop after fungal inoculation into damaged tissue; multiple ones are often due to a septic dissemination of Fusarium in severely immunocompromised patients. An immediate verification of the agents can be life-saving in such cases. Pathogenic Fusarium spp. should be identified at the species level and need to be tested for their susceptibility to antimycotics. In case of multiple lesions, systemic therapy is required. Many strains of Fusarium spp. are susceptible to amphotericin B, voriconazole and posaconazole; itraconazole and terbinafine may be helpful in certain cases.
- Published
- 2012
- Full Text
- View/download PDF
29. Diagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern India.
- Author
-
Rautaraya B, Sharma S, Kar S, Das S, and Sahu SK
- Subjects
- Age Distribution, Aspergillosis diagnosis, Aspergillosis therapy, Aspergillus isolation & purification, Eye Infections, Fungal epidemiology, Eye Infections, Fungal therapy, Female, Fusariosis diagnosis, Fusariosis therapy, Fusarium isolation & purification, Humans, India epidemiology, Keratitis epidemiology, Keratitis therapy, Male, Prevalence, Prognosis, Retrospective Studies, Risk Factors, Sex Distribution, Eye Infections, Fungal microbiology, Keratitis microbiology
- Abstract
Background: Mycotic keratitis is an important cause of corneal blindness world over including India. Geographical location and climate are known to influence the profile of fungal diseases. While there are several reports on mycotic keratitis from southern India, comprehensive clinico-microbiological reports from eastern India are few. The reported prevalence of mycotic keratitis are 36.7%,36.3%,25.6%,7.3% in southern, western, north- eastern and northern India respectively. This study reports the epidemiological characteristics, microbiological diagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern India., Methods: A retrospective review of medical and microbiology records was done for all patients with laboratory proven fungal keratitis., Results: Between July 2006 and December 2009, 997 patients were clinically diagnosed as microbial keratitis. While no organisms were found in 25.4% (253/997) corneal samples, 23.4% (233/997) were bacterial, 26.4% (264/997) were fungal (45 cases mixed with bacteria), 1.4% (14/997) were Acanthamoeba with or without bacteria and 23.4% (233/997) were microsporidial with or without bacteria. Two hundred fifteen of 264 (81.4%, 215/264) samples grew fungus in culture while 49 corneal scrapings were positive for fungal elements only in direct microscopy. Clinical diagnosis of fungal keratitis was made in 186 of 264 (70.5%) cases. The microscopic detection of fungal elements was achieved by 10% potassium hydroxide with 0.1% calcoflour white stain in 94.8%(238/251) cases. Aspergillus species (27.9%, 60/215) and Fusarium species (23.2%, 50/215) were the major fungal isolates. Concomitant bacterial infection was seen in 45 (17.1%, 45/264) cases of mycotic keratitis. Clinical outcome of healed scar was achieved in 94 (35.6%, 94/264) cases. Fifty two patients (19.7%, 52/264) required therapeutic PK, 9 (3.4%, 9/264) went for evisceration, 18.9% (50/264) received glue application with bandage contact lens (BCL) for impending perforation, 6.1% (16/264) were unchanged and 16.3% (43/264) were lost to follow up. Poor prognosis like PK (40/52, 75.9%, p < 0.001) and BCL (30/50, 60%, p < 0.001) was seen in significantly larger number of patients with late presentation (> 10 days)., Conclusions: The relative prevalence of mycotic keratitis in eastern India is lower than southern, western and north-eastern India but higher than northern India, however, Aspergillus and Fusarium are the predominant genera associated with fungal keratitis across India. The response to medical treatment is poor in patients with late presentation., (© 2011 Rautaraya et al; licensee BioMed Central Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
30. An outbreak of Fusarium solani endophthalmitis after cataract surgery in an eye training and research hospital in Istanbul.
- Author
-
Güngel H, Eren MH, Pınarcı EY, Altan C, Baylançiçek DO, Kara N, Gürsel T, Yegenoğlu Y, and Susever S
- Subjects
- Aged, Aged, 80 and over, Antifungal Agents administration & dosage, Cross Infection microbiology, Cross Infection pathology, Cross Infection therapy, Endophthalmitis microbiology, Endophthalmitis pathology, Endophthalmitis therapy, Eye Infections, Fungal microbiology, Eye Infections, Fungal pathology, Eye Infections, Fungal therapy, Female, Fusariosis microbiology, Fusariosis pathology, Fusariosis therapy, Fusarium genetics, Fusarium growth & development, Hospitals, Humans, Male, Middle Aged, Surgical Wound Infection epidemiology, Surgical Wound Infection microbiology, Surgical Wound Infection pathology, Surgical Wound Infection therapy, Vitrectomy, Cataract Extraction adverse effects, Cross Infection epidemiology, Disease Outbreaks, Endophthalmitis epidemiology, Eye Infections, Fungal epidemiology, Fusariosis epidemiology, Fusarium isolation & purification
- Abstract
To report an outbreak of Fusarium solani endophthalmitis after uneventful cataract surgeries performed on the same day in the same operating room. Nine patients underwent phacoemulsification at 4th Clinic of Beyoglu Eye Training and Research Hospital in Istanbul. Cefuroxime axetyl was injected intracamerally from the same vial to all patients at the end of surgery. All patients developed acute postoperative endophthalmitis. Presentation, cultural studies, treatment, clinical responses and risk factors were evaluated. Cultural and DNA sequence findings revealed F. solani. Antifungal therapy was begun and pars plana vitrectomy, intraocular lens and capsule extraction were performed. Corneal involvement was correlated with old age and systemic disease. Fusarium solani should be considered in acute postoperative endophthalmitis. This infection can be controlled with early and aggressive combined antifungal and surgical treatment. The patients with corneal involvement had poor prognosis. It is important to use solutions prepared separately for each patient., (© 2011 Blackwell Verlag GmbH.)
- Published
- 2011
- Full Text
- View/download PDF
31. Combination antifungal therapy for disseminated fusariosis in immunocompromised patients : a case report and literature review.
- Author
-
Liu JY, Chen WT, Ko BS, Yao M, Hsueh PR, Hsiao CH, Kuo YM, and Chen YC
- Subjects
- Adult, Alemtuzumab, Amphotericin B pharmacology, Amphotericin B therapeutic use, Antibodies, Monoclonal, Humanized adverse effects, Antibodies, Monoclonal, Humanized therapeutic use, Antifungal Agents pharmacology, Antineoplastic Agents adverse effects, Antineoplastic Agents therapeutic use, Combined Modality Therapy, Deoxycholic Acid pharmacology, Deoxycholic Acid therapeutic use, Drug Combinations, Drug Therapy, Combination, Fever, Fusariosis microbiology, Fusariosis therapy, Fusarium cytology, Fusarium drug effects, Granulocytes, Humans, Immunocompromised Host, Leukocyte Transfusion, Lymphoma, T-Cell, Cutaneous complications, Lymphoma, T-Cell, Cutaneous drug therapy, Male, Microbial Sensitivity Tests, Neutropenia, Pyrimidines pharmacology, Pyrimidines therapeutic use, Skin Neoplasms complications, Skin Neoplasms drug therapy, Triazoles pharmacology, Triazoles therapeutic use, Voriconazole, Antifungal Agents therapeutic use, Fusariosis diagnosis, Fusarium isolation & purification
- Abstract
Fusarium species are the second leading cause of disseminated mold infections in immunocompromised patients. The high mortality caused by such infections is attributed to the high resistance of Fusarium species to current antifungal agents. We report the first case of disseminated fusariosis after the use of alemtuzumab, an anti-CD52 monoclonal antibody, in a patient who presented with striking cutaneous and oral cavity lesions. Case reports of combination antifungal therapy for disseminated fusariosis in immunocompromised patients were reviewed. Among 19 published cases in the last 10 years plus this patient, the patients in 14 cases (70%) responded positively to combination antifungal therapy. A clinical response was achieved in seven cases before resolution of neutropenia.
- Published
- 2011
- Full Text
- View/download PDF
32. Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment.
- Author
-
Caira M, Trecarichi EM, Mancinelli M, Leone G, and Pagano L
- Subjects
- Antifungal Agents administration & dosage, Aspergillosis epidemiology, Aspergillosis immunology, Aspergillosis microbiology, Aspergillosis therapy, Candidiasis epidemiology, Candidiasis immunology, Candidiasis microbiology, Candidiasis therapy, Fungi drug effects, Fungi growth & development, Fusariosis epidemiology, Fusariosis immunology, Fusariosis microbiology, Fusariosis therapy, Hematologic Neoplasms epidemiology, Hematologic Neoplasms immunology, Hematologic Neoplasms therapy, Hematopoietic Stem Cell Transplantation, Humans, Immunocompromised Host, Incidence, Italy, Male, Mucormycosis epidemiology, Mucormycosis immunology, Mucormycosis microbiology, Mucormycosis therapy, Opportunistic Infections epidemiology, Opportunistic Infections immunology, Opportunistic Infections microbiology, Opportunistic Infections therapy, Risk Factors, Antifungal Agents therapeutic use, Aspergillosis diagnosis, Candidiasis diagnosis, Fusariosis diagnosis, Hematologic Neoplasms microbiology, Mucormycosis diagnosis, Opportunistic Infections diagnosis
- Abstract
Invasive fungal diseases continue to be an important cause of morbidity and mortality in immunosuppressed patients. This is of particular interest, since the progress we made in the treatment of underlying malignancies has led to an increase of the number of persons 'at high risk'. During the last few years, several changes in clinical practice in hematology (new immunosuppressants, hematopoietic stem cell transplants) have influenced the epidemiology of invasive fungal diseases; in particular, cases due to some uncommon etiologic agents are being increasingly reported, making it even more urgent to reconsider differential diagnoses in high-risk patients. A better understanding of epidemiology, risk factors and prognosis appears to be crucial to analyze prevention and diagnostic strategies, as well as to guarantee an early and adequate treatment.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.